Search Results - "Radic, H.D."

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Combined Detection of CD137 and Type 1 Functions Improves Identification and Characterization of the Activated T Lymphocyte Repertoire

    Combined Detection of CD137 and Type 1 Functions Improves Identification and Characterization of the Activated T Lymphocyte Repertoire by Draghi, A., Gokuldass, A., Chamberlain, C.A., Radic, H.D., Svane, I.M., Donia, M.

    Published in Annals of oncology (01-12-2019)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: Implications for the management of irAEs

    Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: Implications for the management of irAEs by Draghi, A., Borch, T.H., Radic, H.D., Chamberlain, C., Gokuldass, A., Svane, I.-M., Donia, M.

    Published in Annals of oncology (01-12-2018)
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression

    T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression by Andersen, R., Borch, T.H., Draghi, A., Gokuldass, A., Rana, M.A.H., Pedersen, M., Nielsen, M., Kongsted, P., Kjeldsen, J.W., Westergaard, M.C.W., Radic, H.D., Chamberlain, C.A., Hölmich, L.R., Hendel, H.W., Larsen, M.S., Met, Ö, Svane, I.M., Donia, M.

    Published in Annals of oncology (01-07-2018)
    “…Almost half of the patients with metastatic melanoma obtain only short-term or no benefit at all from checkpoint inhibitor (CPI) immunotherapy. In this study,…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: